- Home
- CXDO vs ADAG Comparison
CXDO vs ADAG Comparison
Compare CXDO & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CXDO
- ADAG
- Stock Information
- Founded
- CXDO 1995
- ADAG 2011
- Country
- CXDO United States
- ADAG China
- Employees
- CXDO N/A
- ADAG N/A
- Industry
- CXDO Telecommunications Equipment
- ADAG Biotechnology: Pharmaceutical Preparations
- Sector
- CXDO Telecommunications
- ADAG Health Care
- Exchange
- CXDO Nasdaq
- ADAG Nasdaq
- Market Cap
- CXDO 152.4M
- ADAG 91.4M
- IPO Year
- CXDO 1998
- ADAG 2021
- Fundamental
- Price
- CXDO $6.43
- ADAG $1.88
- Analyst Decision
- CXDO Strong Buy
- ADAG Strong Buy
- Analyst Count
- CXDO 3
- ADAG 1
- Target Price
- CXDO $8.50
- ADAG $8.00
- AVG Volume (30 Days)
- CXDO 266.2K
- ADAG 92.2K
- Earning Date
- CXDO 08-05-2025
- ADAG 07-24-2025
- Dividend Yield
- CXDO N/A
- ADAG N/A
- EPS Growth
- CXDO 51.44
- ADAG N/A
- EPS
- CXDO 0.09
- ADAG N/A
- Revenue
- CXDO $62,609,000.00
- ADAG $103,204.00
- Revenue This Year
- CXDO $12.98
- ADAG $6,488.89
- Revenue Next Year
- CXDO $10.91
- ADAG $57.50
- P/E Ratio
- CXDO $72.41
- ADAG N/A
- Revenue Growth
- CXDO 13.85
- ADAG N/A
- 52 Week Low
- CXDO $3.01
- ADAG $1.33
- 52 Week High
- CXDO $7.34
- ADAG $3.58
- Technical
- Relative Strength Index (RSI)
- CXDO 70.77
- ADAG 44.87
- Support Level
- CXDO $5.67
- ADAG $1.74
- Resistance Level
- CXDO $6.57
- ADAG $2.10
- Average True Range (ATR)
- CXDO 0.27
- ADAG 0.10
- MACD
- CXDO 0.10
- ADAG -0.02
- Stochastic Oscillator
- CXDO 90.59
- ADAG 16.67
About CXDO Crexendo Inc.
Crexendo Inc is a provider of cloud communications, UCaaS, call centers, collaboration services, and other cloud business services. The company operates through two segments: Cloud telecommunications and Software Solutions. Its cloud telecommunications segment offers hardware, software, and unified communication solutions for businesses using IP or cloud technology over any high-speed Internet connection. The Software Solutions segment is involved in revenue generation from software licenses, software maintenance support, and professional services. It generates subscription and maintenance support revenue from customer support and other supportive services. The company offers warranties on its products. It derives a majority of its revenue from the Cloud telecommunications segment.
About ADAG Adagene Inc.
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.